ResMed(NYSE: RMD), amedical device company focused on sleep apnea and chronic obstructive pulmonary disease, reported its first-quarter results after the market closed on Thursday, April 27. While ...
Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode.
Earnings call ResMed posted Q2 FY25 revenue of $1.28B, up 10% YoY, with 29% EPS growth and 230 bps gross margin expansion. Management reaffirmed FY25 gross margin guidance (59–60%) and highlighted ...
ResMed Inc.’s (NYSE: RMD) CEO Mick Farrell revealed that Tesla can help manufacture ventilator components along with other automakers and aerospace companies. What Happened Appearing on CNBC’s “Mad ...
Zacks Investment Research on MSN
BSX vs. RMD: Which medical device stock is the stronger play now?
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback